These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19671705

  • 1. Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients.
    Peverelli E, Ermetici F, Filopanti M, Elli FM, Ronchi CL, Mantovani G, Ferrero S, Bosari S, Beck-Peccoz P, Lania A, Spada A.
    Eur J Endocrinol; 2009 Nov; 161(5):687-94. PubMed ID: 19671705
    [Abstract] [Full Text] [Related]

  • 2. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.
    Horvath A, Giatzakis C, Robinson-White A, Boikos S, Levine E, Griffin K, Stein E, Kamvissi V, Soni P, Bossis I, de Herder W, Carney JA, Bertherat J, Gregersen PK, Remmers EF, Stratakis CA.
    Cancer Res; 2006 Dec 15; 66(24):11571-5. PubMed ID: 17178847
    [Abstract] [Full Text] [Related]

  • 3. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.
    Horvath A, Korde L, Greene MH, Libe R, Osorio P, Faucz FR, Raffin-Sanson ML, Tsang KM, Drori-Herishanu L, Patronas Y, Remmers EF, Nikita ME, Moran J, Greene J, Nesterova M, Merino M, Bertherat J, Stratakis CA.
    Cancer Res; 2009 Jul 01; 69(13):5301-6. PubMed ID: 19549888
    [Abstract] [Full Text] [Related]

  • 4. Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
    Faucz FR, Horvath A, Rothenbuhler A, Almeida MQ, Libé R, Raffin-Sanson ML, Bertherat J, Carraro DM, Soares FA, Molina Gde C, Campos AH, Alexandre RB, Bendhack ML, Nesterova M, Stratakis CA.
    J Clin Endocrinol Metab; 2011 Jan 01; 96(1):E135-40. PubMed ID: 20881257
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
    Libé R, Fratticci A, Coste J, Tissier F, Horvath A, Ragazzon B, Rene-Corail F, Groussin L, Bertagna X, Raffin-Sanson ML, Stratakis CA, Bertherat J.
    Clin Cancer Res; 2008 Jun 15; 14(12):4016-24. PubMed ID: 18559625
    [Abstract] [Full Text] [Related]

  • 6. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
    Libé R, Horvath A, Vezzosi D, Fratticci A, Coste J, Perlemoine K, Ragazzon B, Guillaud-Bataille M, Groussin L, Clauser E, Raffin-Sanson ML, Siegel J, Moran J, Drori-Herishanu L, Faucz FR, Lodish M, Nesterova M, Bertagna X, Bertherat J, Stratakis CA.
    J Clin Endocrinol Metab; 2011 Jan 15; 96(1):E208-14. PubMed ID: 21047926
    [Abstract] [Full Text] [Related]

  • 7. Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition.
    Azevedo MF, Horvath A, Bornstein ER, Almeida MQ, Xekouki P, Faucz FR, Gourgari E, Nadella K, Remmers EF, Quezado M, de Alexandre RB, Kratz CP, Nesterova M, Greene MH, Stratakis CA.
    J Clin Endocrinol Metab; 2013 Aug 15; 98(8):E1393-400. PubMed ID: 23771924
    [Abstract] [Full Text] [Related]

  • 8. Rare inactivating PDE11A variants associated with testicular germ cell tumors.
    Pathak A, Stewart DR, Faucz FR, Xekouki P, Bass S, Vogt A, Zhang X, Boland J, Yeager M, Loud JT, Nathanson KL, McGlynn KA, Stratakis CA, Greene MH, Mirabello L.
    Endocr Relat Cancer; 2015 Dec 15; 22(6):909-17. PubMed ID: 26459559
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.
    Vezzosi D, Libé R, Baudry C, Rizk-Rabin M, Horvath A, Levy I, René-Corail F, Ragazzon B, Stratakis CA, Vandecasteele G, Bertherat J.
    J Clin Endocrinol Metab; 2012 Nov 15; 97(11):E2063-9. PubMed ID: 22996146
    [Abstract] [Full Text] [Related]

  • 10. The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme.
    Sbornova I, van der Sande E, Milosavljevic S, Amurrio E, Burbano SD, Das PK, Do HH, Fisher JL, Kargbo P, Patel J, Porcher L, De Zeeuw CI, Meester-Smoor MA, Winkelman BHJ, Klaver CCW, Pocivavsek A, Kelly MP.
    Cells; 2023 Dec 14; 12(24):. PubMed ID: 38132157
    [Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA, Horvath A, Heyerdahl S, Stein E, Robinson-White A, Bossis I, Bertherat J, Carney JA, Stratakis CA.
    Horm Metab Res; 2008 May 14; 40(5):347-53. PubMed ID: 18491255
    [Abstract] [Full Text] [Related]

  • 12. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.
    Clin Endocrinol (Oxf); 2008 Sep 14; 69(3):367-73. PubMed ID: 18419788
    [Abstract] [Full Text] [Related]

  • 13. Functional characteristics and research trends of PDE11A in human diseases (Review).
    Kong G, Lee H, Vo TT, Juang U, Kwon SH, Park J, Park J, Kim SH.
    Mol Med Rep; 2022 Oct 14; 26(4):. PubMed ID: 35929507
    [Abstract] [Full Text] [Related]

  • 14. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
    Adams EF, Brockmeier S, Friedmann E, Roth M, Buchfelder M, Fahlbusch R.
    Neurosurgery; 1993 Aug 14; 33(2):198-203; discussion 203. PubMed ID: 8396223
    [Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression.
    Yuasa K, Kotera J, Fujishige K, Michibata H, Sasaki T, Omori K.
    J Biol Chem; 2000 Oct 06; 275(40):31469-79. PubMed ID: 10906126
    [Abstract] [Full Text] [Related]

  • 16. Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease.
    Qin W, Zhou A, Zuo X, Jia L, Li F, Wang Q, Li Y, Wei Y, Jin H, Cruchaga C, Benitez BA, Jia J.
    Hum Mol Genet; 2021 May 28; 30(9):811-822. PubMed ID: 33835157
    [Abstract] [Full Text] [Related]

  • 17. Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?
    Kelly MP.
    Curr Pharm Des; 2015 May 28; 21(3):389-416. PubMed ID: 25159071
    [Abstract] [Full Text] [Related]

  • 18. Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.
    Yuasa K, Ohgaru T, Asahina M, Omori K.
    Eur J Biochem; 2001 Aug 28; 268(16):4440-8. PubMed ID: 11502204
    [Abstract] [Full Text] [Related]

  • 19. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI, Nesterova M, Stratakis CA.
    Eur J Endocrinol; 2009 Jul 28; 161(1):153-61. PubMed ID: 19429701
    [Abstract] [Full Text] [Related]

  • 20. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA, Mendonca BB, Fragoso MC, Soares IC, Almeida MQ, Moraes MB, Lourenço DM, Alves VA, Bronstein MD, Toledo SP.
    Clinics (Sao Paulo); 2010 Apr 28; 65(4):407-15. PubMed ID: 20454499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.